Document is current
Any future updates will be listed below
-
Authors
Zhang, Yong
Dou, Jin
Dai, Shipeng
Xie, Yuchen
Wang, Hongyu
Chen, Zhongda
Zhuang, Haiwen
Xu, Sanrong
-
Funding
Funding for this research was provided by:
Zhenjiang Science and Technology Plan—Social Development Project (SH2024064)
Jiangsu University Affiliated Hospital “5123” talent program excellent discipline leader training fund
Natural Science Research Project of Guizhou Province (HABL202244)
Innovative Research Group Project of the National Natural Science Foundation of China (HAB2024024)
- License Information
-
More Information
Article History
Received: 19 March 2025
Accepted: 7 July 2025
First Online: 30 July 2025
Declarations
:
: Informed consent and approval were obtained from all the patients and the Ethics Committee of the Affiliated Hospital of Jiangsu University (Study on improvement of liver fibrosis by mesenchymal stem cells, KY2022K0103, Date: 2022-01-03). All the animal studies were performed following the Guidelines for the Care and Use of Laboratory Animals and were approved by the Ethics Committee of Jiangsu University (The role and application of mesenchymal stem cells in regulating ferroptosis in hepatic fibrosis, UJS-IACUC-AP-2024073031, Date: 2024-07-30).
: Informed consent was obtained from all individual participants included in the study.
: The authors declare that they have no competing interests.
